Epigral Ltd (EPIGRAL)
₹874.50
Mkt cap
₹3,773 Cr
P/E ratio
13.90
P/B
1.70
Div yield
0.57%
ROE
15.80%
ROCE
15.30%
EPS (TTM)
₹62.91
Book value
₹515
52W range
807–1,730
Sector
Commodities
Price history
Previous close
Epigral Limited, formerly known as Meghmani Finechem Ltd, incorporated in 2007, is a leading integrated manufacturer of chemicals. [1]
NSE EPIGRALBSE 543332
Health check
Constructive
ValuationCheap
ProfitabilityStrong
GrowthHigh
TechnicalsBearish
52-week range
−49.45% from high₹875
₹807+8.36% from low₹1,730
Current
₹874.50
Prev close
₹907.30
Day
−3.62%
Price performance
1D
−3.89%
1W
−2.57%
1M
−14.35%
3M
−21.11%
6M
−27.00%
1Y
−48.73%
YTD
−29.80%
Financials
Revenue, profit & margin
P/E ratio
13.9×
EPIGRAL is 43% below the sector median of 24.5×
EPIGRAL13.9×
Sector median24.5×
| Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 | Trend | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 455 | 478 | 472 | 525 | 651 | 626 | 645 | 628 | 607 | 587 | 597 | 736 | 705 | |
| Expenses | 360 | 370 | 349 | 369 | 475 | 448 | 463 | 454 | 443 | 455 | 494 | 568 | 526 | |
| Operating Profit | 95 | 108 | 123 | 155 | 176 | 178 | 183 | 173 | 163 | 132 | 103 | 169 | 179 | |
| OPM % | 21% | 23% | 26% | 30% | 27% | 28% | 28% | 28% | 27% | 23% | 17% | 23% | 25% | |
| Other Income | 2 | 1 | 2 | 2 | 2 | 6 | 4 | 3 | 8 | 2 | 6 | -1 | 4 | |
| Interest | 18 | 21 | 20 | 14 | 14 | 27 | -0 | 12 | 23 | 22 | 11 | 16 | 7 | |
| Depreciation | 31 | 32 | 31 | 30 | 33 | 32 | 33 | 34 | 42 | 42 | 43 | 42 | 43 | |
| Profit before tax | 48 | 56 | 74 | 113 | 131 | 124 | 154 | 131 | 107 | 70 | 55 | 111 | 133 | |
| Tax % | 33% | 32% | 34% | 32% | 34% | 35% | 33% | 34% | -50% | 26% | 28% | 26% | 26% | |
| Net Profit | 32 | 38 | 49 | 77 | 86 | 81 | 104 | 87 | 160 | 52 | 39 | 82 | 99 | |
| EPS in Rs | 7.62 | 9.18 | 11.87 | 18.45 | 20.70 | 19.38 | 24.00 | 20.08 | 37.18 | 11.94 | 9.07 | 18.99 | 22.99 | |
| Raw PDF |
Earnings
Results dates & reactionsNext results
2 Nov '26
Fresh quarters land in the Financials table above, tagged NSE until screener catches up.
Avg earnings-day move −0.49% · closed higher next day 1 of last 1
| Q1FY27 | |
|---|---|
| Broadcast | 27 Jul '26 |
| Earnings day | −0.49% |
| +1 day | +0.67% |
| +5 days | −3.61% |
| +15 days | −5.64% |
| +30 days | +1.47% |
| Filing | XBRL |
Corporate actions
Last 6 monthsNo recent corporate actions
Dividends, splits, and bonuses in the last six months show up here.
Results analysis
Shareholding
as of Sep 202668.83%Promoter
Promoters68.83%
FIIs0.99%0.04
DIIs4.89%0.67
Public25.27%0.71
Government0.02%
Ownership trend
Peers
8 companiesValuation vs quality
P/E × ROCE · bubble = market cap| Name | CMP | P/E | Mkt Cap | Div Yld | NP Qtr | Qtr Profit Var | Sales Qtr | Qtr Sales Var | ROCE |
|---|---|---|---|---|---|---|---|---|---|
| Pidilite Inds. | ₹1,461.60 | 55.47 | 1,48,870 | 0.79% | 626 | +6.09% | 4,298 | +20.91% | 31.02% |
| Gujarat Fluoroch | ₹4,248.20 | 75.55 | 46,666 | 0.07% | 219 | +21.43% | 1,588 | +23.97% | 9.64% |
| Navin Fluo.Intl. | ₹8,680.00 | 48.62 | 44,541 | 0.17% | 269 | +81.46% | 1,191 | +57.00% | 20.96% |
| Aether Industri. | ₹1,616.20 | 85.12 | 21,452 | 0.00% | 68 | +21.62% | 347 | +23.96% | 11.92% |
| Deepak Nitrite | ₹1,519.40 | 19.35 | 20,724 | 0.49% | 398 | +234.99% | 3,076 | +61.75% | 11.37% |
| Aarti Industries | ₹435.75 | 26.07 | 15,806 | 0.23% | 168 | +100.00% | 3,669 | +74.71% | 6.86% |
| Fine Organic | ₹5,049.00 | 35.33 | 15,480 | 0.22% | 138 | +23.45% | 694 | +17.98% | 21.47% |
| Epigral | ₹874.50 | 13.88 | 3,773 | 0.57% | 99 | −38.17% | 705 | +16.29% | 15.30% |
| Median: 94 Co. | ₹326.93 | 24.52 | 924 | 0.28% | 12 | +46.54% | 189 | +27.24% | 14.00% |
Filings
Annual reports6
Concall transcripts60
TranscriptJul 2026PPTJul 2026RECJul 2026TranscriptMay 2026PPTMay 2026TranscriptFeb 2026PPTFeb 2026TranscriptNov 2025PPTNov 2025RECNov 2025TranscriptAug 2025PPTAug 2025TranscriptMay 2025PPTMay 2025RECMay 2025TranscriptJan 2025PPTJan 2025RECJan 2025TranscriptNov 2024PPTNov 2024TranscriptJul 2024PPTJul 2024TranscriptApr 2024PPTApr 2024
Credit ratings6
Announcements5
Announcement under Regulation 30 (LODR)-Credit Rating 29 Oct - CRISIL revises Epigral bank facilities rating for Rs 1,050 crore to AA/Stable and A1+.Announcement under Regulation 30 (LODR)-Award_of_Order_Receipt_of_Order 29 Oct - Epigral received AY2023-24 income tax demand of Rs.28.11 crore and plans rectification and appeal.Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation 28 Oct - Conference Call is scheduled on Monday, 2nd November, 2026 to discuss Q2 FY27 Results.Board Meeting Intimation for Meeting Of The Board Scheduled To Be Held On Monday, 2Nd November, 2026 26 Oct - Board to meet on 2 Nov 2026 for Q2 and half-year FY2026 unaudited results.Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation 21 Oct - Epigral Limited has informed about Investor / Analyst Plant Visit on Thursday, 22.10.2026